Anterix Inc. (NASDAQ:ATEX) Shares Purchased by Gabelli Funds LLC

Gabelli Funds LLC boosted its stake in Anterix Inc. (NASDAQ:ATEXGet Rating) by 19.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,500 shares of the company’s stock after purchasing an additional 18,500 shares during the period. Gabelli Funds LLC owned approximately 0.61% of Anterix worth $3,716,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Gamco Investors INC. ET AL increased its holdings in Anterix by 218.9% in the 4th quarter. Gamco Investors INC. ET AL now owns 30,300 shares of the company’s stock valued at $975,000 after purchasing an additional 20,800 shares in the last quarter. Barclays PLC grew its stake in shares of Anterix by 533.8% during the fourth quarter. Barclays PLC now owns 4,944 shares of the company’s stock valued at $159,000 after acquiring an additional 4,164 shares in the last quarter. The Manufacturers Life Insurance Company acquired a new stake in shares of Anterix during the fourth quarter valued at about $226,000. Geode Capital Management LLC grew its stake in shares of Anterix by 5.6% during the fourth quarter. Geode Capital Management LLC now owns 366,891 shares of the company’s stock valued at $11,802,000 after acquiring an additional 19,559 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Anterix by 10.5% during the fourth quarter. JPMorgan Chase & Co. now owns 15,109 shares of the company’s stock valued at $486,000 after acquiring an additional 1,434 shares in the last quarter. 83.53% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Morgan Stanley lowered their target price on Anterix from $63.00 to $42.00 and set an “equal weight” rating for the company in a research note on Friday, February 24th.

Insider Buying and Selling

In related news, Chairman Morgan E. Obrien sold 45,000 shares of Anterix stock in a transaction dated Monday, March 13th. The stock was sold at an average price of $30.04, for a total value of $1,351,800.00. Following the completion of the transaction, the chairman now directly owns 26,947 shares in the company, valued at $809,487.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 3.53% of the company’s stock.

Anterix Price Performance

Shares of Anterix stock opened at $33.34 on Friday. The business has a 50-day moving average of $32.25 and a 200-day moving average of $32.57. The company has a market capitalization of $629.13 million, a PE ratio of -14.56 and a beta of 0.64. Anterix Inc. has a 1-year low of $27.59 and a 1-year high of $49.61.

About Anterix

(Get Rating)

Anterix, Inc operates as a wireless communications company. The firm focuses on commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks, technologies and solutions. It’s solutions include Private LTE and Active Ecosystem. The company was founded by Peter Joel Lasensky and Richard Edward Rohmann in 1997 and is headquartered in Woodland Park, NJ.

Read More

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.